Form 8-K - Current report:
SEC Accession No. 0001649094-25-000084
Filing Date
2025-06-17
Accepted
2025-06-17 16:29:20
Documents
12
Period of Report
2025-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K pcvx-20250612.htm   iXBRL 8-K 51254
  Complete submission text file 0001649094-25-000084.txt   170465

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20250612.xsd EX-101.SCH 1782
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20250612_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20250612_pre.xml EX-101.PRE 13046
14 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20250612_htm.xml XML 2811
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 251053698
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)